pyrazolanthrone has been researched along with Cancer of Gastrointestinal Tract in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Gu, Q; Jiang, B; Kung, HF; Lan, H; Pang, R; Qiao, L; Wang, J; Wong, BC; Zhang, W; Zhang, Y; Zou, B | 1 |
| Chan, AO; De Wang, J; Gu, Q; He, H; Kung, HF; Lin, MC; Sun, YW; Wong, BC; Xia, HH; Yu, LF; Zou, B | 1 |
2 other study(ies) available for pyrazolanthrone and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
c-Jun N-terminal kinase (JNK1) upregulates XIAP-associated factor 1 (XAF1) through interferon regulatory factor 1 (IRF-1) in gastrointestinal cancer.
Topics: Adaptor Proteins, Signal Transducing; Anthracenes; Apoptosis Regulatory Proteins; Cell Line, Tumor; Gastrointestinal Neoplasms; Humans; Interferon Regulatory Factor-1; Interferon-alpha; Intracellular Signaling Peptides and Proteins; Mitogen-Activated Protein Kinase 8; Mutation; Neoplasm Proteins; Phorbol Esters; Promoter Regions, Genetic; Transcriptional Activation; Tumor Necrosis Factor-alpha; Up-Regulation | 2009 |
Induction of apoptosis and cell cycle arrest by a specific c-Jun NH2-terminal kinase (JNK) inhibitor, SP-600125, in gastrointestinal cancers.
Topics: Anthracenes; Apoptosis; Caspases; Cell Division; Cell Proliferation; Enzyme Inhibitors; G2 Phase; Gastrointestinal Neoplasms; Humans; JNK Mitogen-Activated Protein Kinases; RNA, Messenger; Tumor Cells, Cultured | 2006 |